Cargando…
Plasma interleukin-23 and circulating IL-17A(+)IFNγ(+) ex-Th17 cells predict opposing outcomes of anti-TNF therapy in rheumatoid arthritis
OBJECTIVES: TNF-α inhibitors are widely used in rheumatoid arthritis (RA) with varying success. Response to TNF-α inhibition may reflect the evolution of rheumatoid inflammation through fluctuating stages of TNF-α dependence. Our aim was to assess plasma concentrations of Th-17-related cytokines and...
Autores principales: | Millier, Melanie J., Fanning, Niamh C., Frampton, Christopher, Stamp, Lisa K., Hessian, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881822/ https://www.ncbi.nlm.nih.gov/pubmed/35219333 http://dx.doi.org/10.1186/s13075-022-02748-3 |
Ejemplares similares
-
Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation
por: McKelvey, Kelly J., et al.
Publicado: (2018) -
Digital-PCR for gene expression: impact from inherent tissue RNA degradation
por: Millier, Melanie J., et al.
Publicado: (2017) -
Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis
por: Hillyer, Philippa, et al.
Publicado: (2009) -
Interleukin-17A and interleukin-23 in morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2012) -
Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
por: Chen, Der-Yuan, et al.
Publicado: (2011)